Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology
Authors
Keywords
-
Journal
MEDICINE
Volume 102, Issue 42, Pages e35460
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-20
DOI
10.1097/md.0000000000035460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Toxicogenomics Database (CTD): update 2023
- (2022) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- UniProt: the Universal Protein Knowledgebase in 2023
- (2022) et al. NUCLEIC ACIDS RESEARCH
- Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
- (2022) Wensheng Che et al. Frontiers in Endocrinology
- Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
- (2021) Honglin Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial
- (2021) Samer Gawrieh et al. HEPATOLOGY
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Maternal nicotine exposure aggravates metabolic associated fatty liver disease via PI3K/Akt signaling in adult offspring mice
- (2021) Shu‐Jing Huang et al. LIVER INTERNATIONAL
- A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
- (2021) Guillaume Canaud et al. Orphanet Journal of Rare Diseases
- Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016
- (2021) Pegah Golabi et al. Clinical Gastroenterology and Hepatology
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
- (2021) Ying Zhou et al. NUCLEIC ACIDS RESEARCH
- Protein Function Prediction Based on PPI Networks: Network Reconstruction vs Edge Enrichment
- (2021) Jiaogen Zhou et al. Frontiers in Genetics
- Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
- (2020) Stefano Fiorucci et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
- (2020) Divya P. Kumar et al. Scientific Reports
- A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease
- (2020) Fatemeh Naeini et al. Advances in Nutrition
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1
- (2020) Yi Qiao Hua et al. PHYTOMEDICINE
- Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/ HO ‐1 and AMPK signalling pathways
- (2019) Bingyu Shen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Naringenin attenuates nonalocholic fatty liver disease by downregulating NLRP3/NF‐κB pathway in mice
- (2019) Qinyu Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
- (2018) Romeo Papazyan et al. JOURNAL OF LIPID RESEARCH
- Beneficial effects of naringenin in liver diseases: Molecular mechanisms
- (2018) Erika Hernández-Aquino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis
- (2018) Bei Li et al. Canadian Journal of Gastroenterology and Hepatology
- Modulation of Insulin Resistance in NAFLD
- (2018) Reenam Khan et al. HEPATOLOGY
- The role of hypoxia-inducible factors in metabolic diseases
- (2018) Frank J. Gonzalez et al. Nature Reviews Endocrinology
- ETCM: an encyclopaedia of traditional Chinese medicine
- (2018) Hai-Yu Xu et al. NUCLEIC ACIDS RESEARCH
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- MAPK1/3 regulate hepatic lipid metabolism via ATG7-dependent autophagy
- (2016) Yuzhong Xiao et al. Autophagy
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
- (2016) Hua Yan et al. Molecular Medicine Reports
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
- (2016) Janet Piñero et al. NUCLEIC ACIDS RESEARCH
- Naringenin attenuates CCl4-induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats
- (2014) Mohammad Ali Esmaeili et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
- (2014) Jinlong Ru et al. Journal of Cheminformatics
- PubChem's BioAssay Database
- (2011) Y. Wang et al. NUCLEIC ACIDS RESEARCH
- Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation
- (2008) R. R Ortiz-Andrade et al. DIABETES OBESITY & METABOLISM
- Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor
- (2008) Emma M. Allister et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started